Works by Díaz‐Cerezo, Silvia


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8

    Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 9, p. 3569, doi. 10.1007/s12325-024-02938-2
    By:
    • Botana López, Manuel;
    • Camafort Babkowski, Miguel;
    • Campuzano Ruiz, Raquel;
    • Cebrián Cuenca, Ana;
    • Gargallo Fernández, Manuel;
    • David de Paz, Héctor;
    • Redondo-Antón, Jennifer;
    • Artime, Esther;
    • Díaz-Cerezo, Silvia;
    • Rubio de Santos, Miriam
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.

    Published in:
    Patient Preference & Adherence, 2025, v. 19, p. 1231, doi. 10.2147/PPA.S509483
    By:
    • Díaz-Cerezo, Silvia;
    • Artime, Esther;
    • Redondo-Antón, Jennifer;
    • Duque, Natalia;
    • Spaepen, Erik;
    • Cruz, Miguel Ángel Mangas;
    • Arnas-Leon, Claudia;
    • Olveira, Gabriel;
    • Rodríguez, Irene Rodríguez;
    • Alagarda, María Teresa Julián;
    • Valdés, Nuria;
    • Merchante, Agustín Ángel;
    • Masmiquel, Lluís;
    • Santos, Miriam Rubio-de
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study.

    Published in:
    Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1319, doi. 10.1007/s40744-023-00584-8
    By:
    • Joven, Beatriz;
    • Hernández Sánchez, Raquel;
    • Pérez-Pampín, Eva;
    • Aragón Díez, Ángel;
    • Almodóvar, Raquel;
    • Martínez-Ferrer, Ángels;
    • Belzunegui, Joaquín;
    • Rubio, Esteban;
    • Díaz-Cerezo, Silvia;
    • Moyano, Sebastián;
    • Gómez-Barrera, Manuel;
    • Yébenes, María;
    • Núñez, Mercedes
    Publication type:
    Article
    26

    Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).

    Published in:
    2022
    By:
    • Hernández-Cruz, Blanca;
    • Rosas, José;
    • Díaz-Torné, César;
    • Belzunegui, Joaquín;
    • García-Vicuña, Rosario;
    • Inciarte-Mundo, José;
    • Pons, Ana;
    • Millán, Ana M.;
    • Jeria-Navarro, Sicylle;
    • Valero, Jesús A.;
    • García-Castañeda, Noelia;
    • Valero, Cristina;
    • Llorente, Irene;
    • Calvo, Alberto;
    • Díaz-Cerezo, Silvia;
    • Núñez, Mercedes
    Publication type:
    Correction Notice
    27

    Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study).

    Published in:
    Rheumatology & Therapy, 2022, v. 9, n. 2, p. 589, doi. 10.1007/s40744-021-00423-8
    By:
    • Hernández-Cruz, Blanca;
    • Rosas, José;
    • Díaz-Torné, César;
    • Belzunegui, Joaquín;
    • García-Vicuña, Rosario;
    • Inciarte-Mundo, José;
    • Pons, Ana;
    • Millán, Ana M.;
    • Jeria-Navarro, Sicylle;
    • Valero, Jesús A.;
    • García-Castañeda, Noelia;
    • Valero, Cristina;
    • Llorente, Irene;
    • Calvo, Alberto;
    • Díaz-Cerezo, Silvia;
    • Núñez, Mercedes
    Publication type:
    Article
    28